Arphra/Issuer/RDY

RDY

Dr. Reddy's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericINUSDCountry macro →

$13.03

LiveJun 02, 2026

AI Brief

Market cap

$10.85B

52w range

12.19 – 16.17

P / E

—

EPS

—

Volume

1.5M

Revenue · FY

$353.47B

Explain this page

Arphra AIPlain-English read on Dr. Reddy's Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for RDY.

Peers

No peer list available for RDY.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-1.73%	-4.89%	-5.03%	-8.56%	-7.78%	-7.19%	-11.12%	+15.51%	-9.45%	+38.76%	+1190.10%

Aftermarket

Live

Jun 03, 12:39 PM

Last trade

$13.03

1 sh

Bid

$13.00

250 sh

Ask

$13.34

100 sh

Spread

$0.340

Sector & industry today

Live

Sectors

Technology
+1.59%
Industrials
+1.50%
Energy
+1.40%
Basic Materials
+1.36%
Utilities
+0.94%
Consumer Cyclical
+0.45%
Real Estate
+0.37%
Consumer Defensive
+0.28%
Financial Services
+0.05%
Healthcare
-0.26%
Communication Services
-0.39%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-1.54%
Hardware, Equipment & Parts
+5.17%
Computer Hardware
-4.64%
REIT - Office
+4.28%
Communication Equipment
+4.02%
Electronic Gaming & Multimedia
-3.94%
Real Estate - Services
+3.82%
Agricultural - Machinery
+3.64%
Auto - Parts
+3.58%
Oil & Gas Energy
+3.45%
Information Technology Services
+3.19%
Copper
+3.00%

Fair value

Football field →

Weighted blend

$799.74

+6037.70% vs spot

Recommendation

Strong Buy

4 of 4 methods

Method spread

4bull0bear

±5% threshold

Total assets

$567.88B

Total debt

$75.81B

Cash & equiv

$15.06B

Operating CF

$56.65B

Free cash flow

$32.1B

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$353.47B	$48.87B	$45.09B	$53.92	+12.76%